Skip to main content

Analysis of Galectin-Binding Receptors on B Cells

  • Protocol
  • First Online:
Galectins

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2442))

Abstract

The reported roles of the β-galactoside-binding lectin family, known as galectins, in disease development have been advancing at a remarkable pace. Galectins and their glycan counter-receptor ligands are now considered key functional determinants in malignant and metastatic progression, tumor immune evasion, autoimmunity, and immune homeostasis. Their influence in these processes is elicited through coordinated expression in tumor, immune and stromal cellular compartments. While analysis of galectin levels in related research efforts is routinely performed through immunoassays and RT-qPCR, detection, and identification of glycan counter-receptor ligands in their native form on the cell surface has lagged. In this report, we present methods to detect and identify glycan counter-receptor ligands to galectin (Gal)-3 and Gal-9—two galectins at the crosshairs of cancer and immunology research. As a model, we will describe (1) isolation of human B-cell subsets from fresh tonsil tissue, (2) assaying of Gal-3/-9-binding activities on human B cells, and (3) identifying Gal-3/-9 ligands on human B-cell surfaces. These methods, of course, can be implemented on any cell type to provide a cellular and molecular context capable of transmitting a galectin-mediated phenotype. Establishing a galectin-binding activity on specific counter-receptor ligand(s) can help unearth potential critical determinants capable of delivering cellular signals required for disease progression. These advances open new avenues of research investigation that result in novel therapeutic targets and approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Broussard G, Damania B (2020) KSHV: immune modulation and immunotherapy. Front Immunol 10:3084

    Article  Google Scholar 

  2. Navegantes KC, De Souza GR, PAT P et al (2017) Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity. J Transl Med 15:36

    Article  Google Scholar 

  3. Tan L, Wu H, Liu Y et al (2016) Recent advances of exosomes in immune modulation and autoimmune diseases. Autoimmunity 49:357–365

    Article  CAS  Google Scholar 

  4. Van De Veen W, Akdis M (2019) The use of biologics for immune modulation in allergic disease. J Clin Invest 129:1452–1462

    Article  Google Scholar 

  5. Earl LA, Bi S, Baum LG (2010) N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death. J Biol Chem 285:2232–2244

    Article  CAS  Google Scholar 

  6. Cummings RD, Liu FT (2009) Galectins. In: Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (eds) Essentials of glycobiology. Cold Spring Harbor Laboratory Press The Consortium of Glycobiology Editors, La Jolla, California., Cold Spring Harbor (NY)

    Google Scholar 

  7. Fouillit M, Joubert-Caron R, Poirier F et al (2000) Regulation of CD45-induced signaling by galectin-1 in Burkitt lymphoma B cells. Glycobiology 10:413–419

    Article  CAS  Google Scholar 

  8. Hoyer KK, Pang M, Gui D et al (2004) An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. Am J Pathol 164:893–902

    Article  CAS  Google Scholar 

  9. Perillo NL, Pace KE, Seilhamer JJ et al (1995) Apoptosis of T cells mediated by galectin-1. Nature 378:736–739

    Article  CAS  Google Scholar 

  10. Rabinovich GA, Riera CM, Landa CA et al (1999) Galectins: a key intersection between glycobiology and immunology. Braz J Med Biol Res 32:383–393

    Article  CAS  Google Scholar 

  11. Cedeno-Laurent F, Barthel SR, Opperman MJ et al (2010) Development of a nascent galectin-1 chimeric molecule for studying the role of leukocyte galectin-1 ligands and immune disease modulation. J Immunol 185:4659–4672

    Article  CAS  Google Scholar 

  12. Mendez-Huergo SP, Hockl PF, Stupirski JC et al (2019) Clinical relevance of Galectin-1 and Galectin-3 in rheumatoid arthritis patients: differential regulation and correlation with disease activity. Front Immunol 9:3057

    Article  Google Scholar 

  13. Johannes L, Jacob R, Leffler H (2018) Galectins at a glance. J Cell Sci 131:jcs208884

    Article  Google Scholar 

  14. Cedeno-Laurent F, Dimitroff CJ (2012) Galectin-1 research in T cell immunity: past, present and future. Clin Immunol 142:107–116

    Article  CAS  Google Scholar 

  15. Cedeno-Laurent F, Opperman M, Barthel SR et al (2012) Galectin-1 triggers an immunoregulatory signature in Th cells functionally defined by IL-10 expression. J Immunol 188:3127–3137

    Article  CAS  Google Scholar 

  16. Cedeno-Laurent F, Watanabe R, Teague JE et al (2012) Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma. Blood 119:3534–3538

    Article  CAS  Google Scholar 

  17. Stillman BN, Hsu DK, Pang M et al (2006) Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J Immunol 176:778–789

    Article  CAS  Google Scholar 

  18. Clark MC, Pang M, Hsu DK et al (2012) Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death. Blood 120:4635–4644

    Article  CAS  Google Scholar 

  19. Giovannone N, Antonopoulos A, Liang J et al (2018) Human B cell differentiation is characterized by progressive remodeling of O-linked Glycans. Front Immunol 9:2857

    Article  CAS  Google Scholar 

  20. Giovannone N, Liang J, Antonopoulos A et al (2018) Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans. Nat Commun 9:3287

    Article  CAS  Google Scholar 

  21. Giovannone N, Smith LK, Treanor B et al (2018) Galectin-glycan interactions as regulators of B cell immunity. Front Immunol 9:2839

    Article  CAS  Google Scholar 

  22. Johnston A, Sigurdardottir SL, Ryon JJ (2009) Isolation of mononuclear cells from tonsillar tissue. Curr Protoc Immunol. Chapter 7:Unit 7.8

    Google Scholar 

Download references

Acknowledgments

This methods chapter was supported by the National Institutes of Health (NIH)/National Cancer Institute (NCI) Alliance of Glycobiologists for Cancer Research: Biological Tumor Glycomics Laboratory (U01 CA225644 to CJ Dimitroff) and the NIH/National Institute of Allergy and Infectious Diseases (NIAID) (R21 AI146368 to CJ Dimitroff). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles J. Dimitroff .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Chakraborty, A., Mohammed, N.B.B., Bernasconi, A.E., Dimitroff, C.J. (2022). Analysis of Galectin-Binding Receptors on B Cells. In: Stowell, S.R., Arthur, C.M., Cummings, R.D. (eds) Galectins. Methods in Molecular Biology, vol 2442. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2055-7_30

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-2055-7_30

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-2054-0

  • Online ISBN: 978-1-0716-2055-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics